Fmoc-L-Orn(ivDde)-OH

Fmoc-L-Orn(ivDde)-OH is an Fmoc-protected L-ornithine derivative bearing an ivDde (1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethylidene) side-chain protecting group on the δ-amino functionality. The molecule combines a stereochemically defined α-amino acid backbone with a protected primary amine that can be selectively unmasked under orthogonal deprotection conditions, while the Fmoc group supports base-labile N-terminal peptide chemistry. The carboxylic acid remains available for amide bond formation, and the protected side chain reduces undesired side reactions during peptide assembly. The chiral, amino acid-derived framework and orthogonally protected amine enable controlled peptide coupling, segment assembly, and downstream generation of δ-functional ornithine residues for biochemical and materials-oriented synthesis.

1. Peptide Synthesis

Fmoc-L-Orn(ivDde)-OH is used in peptide synthesis workflows where orthogonal protection of the side-chain amine is required for stepwise construction of ornithine-containing sequences. The Fmoc group provides standard N-terminal protection for iterative coupling and deprotection cycles, while the ivDde-protected δ-amine suppresses cross-reactivity and helps maintain sequence fidelity during chain elongation. The free carboxylic acid participates in peptide coupling to generate amide linkages, enabling incorporation as a protected amino acid building block at defined positions. Selective unmasking of the δ-amine after assembly can then enable side-chain functionalization or cyclization strategies in peptide analogs, supporting robust peptide construction for research and industrial custom synthesis.

2. Side-Chain Functionalization

Fmoc-L-Orn(ivDde)-OH supports side-chain functionalization strategies that rely on controlled availability of the ornithine δ-amino group after orthogonal deprotection. The ivDde group is designed to mask the primary amine during earlier synthetic steps, reducing formation of undesired byproducts such as over-alkylation or side-chain acylation. Once deprotected, the δ-amino functionality can be converted into urea, amide, sulfonamide, or conjugation-ready derivatives, enabling targeted modification of peptide scaffolds and peptidomimetics. Downstream functionalization from a defined chiral amino acid precursor supports structure-guided generation of new molecular entities for chemical biology and synthetic methodology development.

3. Protected Amino Acids

Fmoc-L-Orn(ivDde)-OH serves as a protected amino acid intermediate for preparing ornithine derivatives with orthogonal protecting-group logic that is compatible with Fmoc-based peptide chemistry. The combination of an Fmoc-protected α-amino group and an ivDde-protected δ-amine provides a two-site protection scheme that can be selectively manipulated to control chemoselectivity across multi-step syntheses. The carboxylic acid functionality enables conversion into activated coupling partners or direct incorporation into peptide chains, supporting protected amino acid synthesis and intermediate preparation. This protection architecture is particularly relevant for building chiral, side-chain-defined amino acid derivatives used in fine chemical synthesis and peptide manufacturing campaigns requiring predictable deprotection and coupling behavior.

4. Bioconjugation Chemistry

Fmoc-L-Orn(ivDde)-OH can be applied to bioconjugation chemistry where ornithine-derived amine handles are introduced into peptide or protein-reactive constructs with controlled timing. The protected δ-amine limits non-specific conjugation during earlier assembly stages, while the orthogonal deprotection allows generation of a defined primary amine for subsequent coupling to electrophiles such as activated esters, isothiocyanates, or aldehyde-based linkers. The chiral amino acid backbone and amide-forming carboxyl group enable incorporation into peptide carriers that can be used as scaffolds for labeling, affinity probes, or reagent generation in biochemical workflows. The resulting conjugation-ready ornithine residues support downstream formation of amine-functional biomolecule derivatives through amino acid chemistry-compatible synthetic routes.

5. Process Chemistry Intermediate

Fmoc-L-Orn(ivDde)-OH is suitable for process chemistry intermediate preparation in settings that require reproducible handling of orthogonally protected amino acids for peptide and specialty chemical manufacturing. The Fmoc group provides a well-characterized base-labile protection site for N-terminal deprotection, while the ivDde-protected δ-amine supports selective side-chain unmasking to reduce impurity formation during sequential coupling and purification steps. The presence of a free carboxylic acid enables standardized activation and incorporation into larger synthetic sequences, aligning with scalable peptide building block production practices. The defined stereochemistry and dual-site protection strategy support consistent downstream derivative formation, including ornithine-containing peptide analogs and functionalized amino acid intermediates used in industrial fine chemical synthesis.

6. Peptidomimetics And SAR Studies

Fmoc-L-Orn(ivDde)-OH is applied in peptidomimetic construction and structure-activity relationship studies where precise placement of an ornithine side-chain amine influences molecular recognition and binding-site interactions. The δ-amino group, protected during assembly and then revealed when needed, enables controlled introduction of hydrogen-bonding motifs and cationic or nucleophilic functionality into peptide-like scaffolds. The Fmoc-based incorporation supports systematic generation of analog series with defined stereochemical configuration at the α-carbon, supporting comparative SAR investigations across closely related structures. The ability to generate side-chain-modified derivatives from a single chiral, protected amino acid precursor supports efficient library synthesis and analytical reference preparation in applied medicinal chemistry and chemical biology research.

1. Emu oil in combination with other active ingredients for treating skin imperfections

2. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore

3. TMEM16F and dynamins control expansive plasma membrane reservoirs

4. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

5. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency